Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting

Seizure

Volumn 16, Issue 2, 2007, Pages 173-184

  Allain, Hervé ^a   Schück, Stéphane ^a   Nachit Ouinekh, Fatima ^b   Plouin, Perrine ^c   Brunon, Anne Marie ^d   Boulliat, Jacques ^e   Mercier, Florence ^f   Slama, Alain ^b   Baulac, Michel ^g   Hasnaoui, Abdelkader El ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b GLAXOSMITHKLINE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Clinique du Tonkin   (France)

^e Centre Hospitalier de Bourg en Bresse   (France)

^f STAT PROCESS   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Epilepsy; Lamotrigine; QOLIE 31; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENERGY; EPILEPSY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NATURALISTIC INQUIRY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEIZURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TRIAZINES;

EID: 33846803995     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2006.11.009     Document Type: Article

References (49)

1. Wagner A.K., Bungay K.M., Kosinski M., Bromfield E.B., and Ehrenberg B.L. The health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy 16 (1996) 1-9
2. Baker G.A., Jacoby A., Buck D., Stalgis C., and Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 38 (1997) 353-362
3. Kline L.N., Rentz A.M., and Grace E.M. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia 39 (1998) 965-977
4. Wagner A.K., Keller S.D., Kosinski M., Baker G.A., Jacoby A., Hsu M.A., et al. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Qual Life Res 4 (1995) 115-134
5. Cowan J., and Baker G.A. A review of subjective impact measures for use with children and adolescents with epilepsy. Qual Life Res 13 (2004) 1435-1443
6. Ware J.E., and Sherbourne C.D. The MOS 36-item short form health survey (SF-36). Med Care 30 (1992) 473-483
7. Selai C.E., Elstner K., and Trimble M.R. Quality of life pre and post epilepsy surgery. Epilepsy Res 38 (2000) 67-74
8. Gillham R., Baker G., Thompson P., Birbeck K., McGuire A., Tomlinson L., et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 24 (1996) 47-55
9. Chadwick D. Measuring antiepileptic therapies: the patient vs the physician viewpoint. Neurology 44 Suppl. 8 (1994) S24-S28
10. Abetz L., Jacoby A., Baker G.A., and McNulty P. Patient-based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL. Epilepsia 41 (2000) 1119-1128
11. Baker G.A., Jacoby A., Smith D.F., Dewey M.E., and Chadwick D.W. Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy. Epilepsia 35 (1994) 591-596
12. Sabaz M., Cairns D.R., Lawson J.A., Nheu N., Bleasel A.F., and Bye A.M. Validation of a new quality of life measure for children with epilepsy. Epilepsia 41 (2000) 765-774
13. Vickrey BG, Perrine KR, Hays RD, Hermann BO, Cramer JA, Meader KJ, et al. Quality of life in epilepsy (QOLIE-31) (version 1.0); scoring manual and patient inventory. Santa Monica, CA: RAND; 1993.
14. Devinsky O., Vickrey B.G., Cramer J., Perrine K., Hermann B., and Meador K. Development of the quality of life in epilepsy inventory. Epilepsia 36 (1995) 1089-1104
15. Cramer J.A., Perrine K., Devinsky O., Bryant-Comstock L., Meador K., and Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39 (1998) 81-88
16. Cramer J.A., Perrine K., Devinsky O., and Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 37 (1996) 577-582
17. Cramer J.A., Westbrook L.E., Devinsky O., Perrine K., Glassman M.B., and Camfield C. Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48. Epilepsia 40 (1999) 1114-1121
18. Birbeck G.L., Kim S., Hays R.D., and Vickrey B.G. Quality of life measures in epilepsy: how well can they detect change over time?. Neurology 54 (2000) 1822-1827
19. Birbeck G.L., Hays R.D., Cui X., and Vickrey B.G. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43 (2002) 535-538
20. Weibe S., and Eliasziw M. Changes in quality of life in epilepsy: how large must they be to be real?. Epilepsia 42 (2001) 113-118
21. Wiebe S., Matijevic S., Eliasziw M., and Derry P.A. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 73 (2002) 116-120
22. Cramer J.A., Arrigo C., van Hammee G., and Bromfield E.B. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res 41 (2000) 28-29
23. Cramer J.A., et al. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav 4 (2003) 118-123
24. Herranz J.L., et al. Oxcarbacepina en monoterapia en 324 pacientes con crisis parciales (estudio TRINOVA). Rev Neurol 39 (2004) 601-606
25. Kaminow L., Schimschock J.R., Hammer A.E., and Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behav 4 (2003) 659-666
26. Picot M.C., Crespel A., Daures J.P., Baldy-Moulinier M., and El Hasnaoui A. Psychometric validation of the French version of the quality of life in epilepsy inventory (QOLIE-31): comparison with a generic health related quality of life questionnaire. Epileptic Disord 6 (2004) 275-285
27. Leschek-Gelman L.M., Groenke D.A., Hammer A.E., and Messenheimer J.A. Evaluation of seizure control, adverse events, and quality of life in patients converting to lamotrigine monotherapy. Epilepsia 43 Suppl. 8 (2002) 199
28. Selai C.E., Smith K., and Trimble M.R. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure 8 (1999) 8-13
29. Smith D., Baker G., Davies G., Dewey M., and Chadwick D.W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34 (1993) 312-322
30. Jacoby A., Baker G., Bryant-Comstock L., Philips S., and Bamford C. Lamotrigine add-on therapy is associated with improvement in mood in patients with severe epilepsy. Epilepsia 37 Suppl. 5 (1996) 202
31. Chris Sackellares J., Jacqueline Kwong W., Vuong A., Hammer A.E., and Barrett P.S. Lamotrigine monotherapy improves health-related quality of life in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 3 (2002) 376-382
32. Bryant-Comstock L., Kane K., and Moorat A. Quality of life improvement in patients treated with lamotrigine compared with valproate. Epilepsia 40 Suppl. 9 (1990) 98
33. Cramer J.A., Hammer A.E., and Kustra R.P. Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy Behav 5 (2004) 224-230
34. Steiner T.J., Dellaportas C.I., Findley L.J., Gross M., Gibberd F.B., and Perkin G.D. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 40 (1999) 601-607
35. Gillham R., Kane K., Bryant-Comstock L., and Brodie M.J. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 9 (2000) 375-379
36. Aldenkamp A.P., and Baker G. A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav 2 (2001) 85-91
37. Baulac M., Boulliat J., Plouin P., Slama A., Schück S., Allain H., et al. Etude pharmaco-epidemiologique de I'utilisation de la lamotrigine chez les sujets avec I'épilepsie de plus de 12 ans en France. Neurologies 9 (2006) 600-608
38. Buck D., Jacoby A., Baker G.A., Ley H., and Steen N. Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 8 (1999) 675-685
39. Kotsopoulos I.A., Evers S.M., Ament A.J., Kessels F.G., de Krom M.C., and Twellaar M. The costs of epilepsy in three different populations of patients with epilepsy. Epilepsy Res 54 (2003) 131-140
40. Salas-Puig J., et al. Seguridad del levetiracetam como tratamiento adyuvante en la epilepsia: el estudio SKATE en España. Rev Neurol 38 (2004) 1117-1122
41. Herranz J.L., Sol J.M., and Hernandez G. Gabapentina en niños y en adolescentes con epilepsia. Rev Neurol 30 (2000) 1141-1145
42. Herranz J.L. Gabapentina en niños y en adolescentes con epilepsia. Rev Neurol 34 (2002) 384-387
43. Cramer J.A., et al. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia 41 (2000) 868-874
44. Bruni J., et al. Outcome evaluation of gabapentin as add-on therapy for partial seizures. Can J Neurol Sci 25 (1998) 134-140
45. Beran R., Berkovic S., Black A., Danta G., Dunne J., Frasca J., et al. Australian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures. Epilepsia 42 (2001) 1335-1339
46. Baker G.A., et al. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy-a Canadian study. Seizure 11 (2002) 6-15
47. Dodrill C.B., Arnett J.L., Sommerville K.W., and Sussman N.M. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology 43 (1993) 2501-2507
48. Dodrill C.B., Arnett J.L., Sommerville K.W., and Sussman N.M. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia 36 (1995) 164-173
49. Kaiser S., Selai C.E., and Trimble M.R. Long-term follow-up of topiramate and lamotrigine: a perspective on quality of life. Seizure 11 (2002) 356-360